Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea

World Journal of Gastroenterology

Volumn 17, Issue 37, 2011, Pages 4218-4224

  Chen, Chien Chang ^a,b   Chang, Chee Jen ^a,b   Lin, Tzou Yien ^a,b   Lai, Ming Wei ^a,b   Chao, Hsun Chin ^a,b   Kong, Man Shan ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Clark scores; Diarrhea; Generalized estimating equations; Lactoferrin; Vesikari scores

Indexed keywords

C REACTIVE PROTEIN; LACTOFERRIN;

ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES LEVEL; FEMALE; FEVER; HUMAN; INFANT; INFECTIOUS DIARRHEA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONITORING; NONHUMAN; NOROVIRUS; PUS; SALMONELLA; VOMITING;

EID: 80555134764     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i37.4218     Document Type: Article

References (31)

1. Miyauchi H, Hashimoto S, Nakajima M, Shinoda I, Fukuwatari Y, Hayasawa H. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain. Cell Immunol 1998; 187: 34-37
2. Curran CS, Demick KP, Mansfield JM. Lactoferrin activates macrophages via TLR4-dependent and-independent signaling pathways. Cell Immunol 2006; 242: 23-30
3. Ellison RT. The effects of lactoferrin on gram-negative bacteria. Adv Exp Med Biol 1994; 357: 71-90
4. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 1999; 74: 486-498
5. Crouch SP, Slater KJ, Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 1992; 80: 235-240
6. Shau H, Kim A, Golub SH. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leukoc Biol 1992; 51: 343-349
7. Dhennin-Duthille I, Masson M, Damiens E, Fillebeen C, Spik G, Mazurier J. Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J Cell Biochem 2000; 79: 583-593
8. Zimecki M, Mazurier J, Spik G, Kapp JA. Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 1995; 86: 122-127
9. Conlan JW, North RJ. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect Immun 1992; 60: 5164-5171
10. Perdomo JJ, Gounon P, Sansonetti PJ. Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. J Clin Invest 1994; 93: 633-643
11. Sugi K, Saitoh O, Hirata I, Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol 1996; 91: 927-934
12. Guerrant RL, Araujo V, Soares E, Kotloff K, Lima AA, Cooper WH, Lee AG. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol 1992; 30: 1238-1242
13. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22: 259-267
14. Clark HF, Borian FE, Bell LM, Modesto K, Gouvea V, Plotkin SA. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988; 158: 570-587
15. Hardin JW, Hilbe JM. Generalized estimating equations.2nd ed. Boca Raton, FL: Chapman and Hall/CRC, 2003
16. Pulimood AB, Mathan MM, Mathan VI. Quantitative and ultrastructural analysis of rectal mucosal mast cells in acute infectious diarrhea. Dig Dis Sci 1998; 43: 2111-2116
17. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003; 98: 1309-1314
18. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995; 80: 252-267
19. Pruitt KM, Rahemtulla F, Mønsson-Rahemtulla B. Innate humoral factors. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, editors. Handbook of mucosal immunology. San Diego, Calif: Academic Press, Inc. 1994-5370
20. Raqib R, Wretlind B, Andersson J, Lindberg AA. Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis 1995; 171: 376-384
21. Raqib R, Lindberg AA, Wretlind B, Bardhan PK, Andersson U, Andersson J. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun 1995; 63: 289-296
22. Pfefferkorn MD, Boone JH, Nguyen JT, Juliar BE, Davis MA, Parker KK. Utility of fecal lactoferrin in identifying Crohn disease activity in children. J Pediatr Gastroenterol Nutr 2010; 51: 425-428
23. Masoodi I, Kochhar R, Dutta U, Vaishnavi C, Prasad KK, Vaiphei K, Kaur S, Singh K. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis. J Gastroenterol Hepatol 2009; 24: 1768-1774
24. Choi SW, Park CH, Silva TM, Zaenker EI, Guerrant RL. To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea. J Clin Microbiol 1996; 34: 928-932
25. Evaluation of a New Latex Agglutination Test for Fecal Lactoferrin in Travelers' Diarrhea. J Travel Med 1994; 1: 68-71
26. Yong WH, Mattia AR, Ferraro MJ. Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease. J Clin Microbiol 1994; 32: 1360-1361
27. Huicho L, Campos M, Rivera J, Guerrant RL. Fecal screening tests in the approach to acute infectious diarrhea: a scientific overview. Pediatr Infect Dis J 1996; 15: 486-494
28. Gotham IJ, Sottolano DL, Hennessy ME, Napoli JP, Dobkins G, Le LH, Burhans RL, Fage BI. An integrated information system for all-hazards health preparedness and response: New York State Health Emergency Response Data System. J Public Health Manag Pract 2007; 13: 486-496
29. Hayakawa T, Jin CX, Ko SB, Kitagawa M, Ishiguro H. Lactoferrin in gastrointestinal disease. Intern Med 2009; 48: 1251-1254
30. Hicks S, Nataro JP, Knutton S, Phillips AD. Cytotoxic effects of enteroaggregative Escherichia coli (EAggEC) on human intestinal mucosa in vitro. J Pediatr Gastroenterol Nutr 1996; 22: 432
31. Bouckenooghe AR, Dupont HL, Jiang ZD, Adachi J, Mathewson JJ, Verenkar MP, Rodrigues S, Steffen R. Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers. Am J Trop Med Hyg 2000; 62: 711-713